最新观点
Insights From Our Experts
Articles
Global Pharma Heads Into Uncharted Territories in Pricing and Regulation: May 2021
Policymakers around the world continue to face unprecedented decisions about pharmaceuticals and the healthcare industry. With rapid industry innovation comes new challenges, unanswered questions and intense debates on pricing and regulation. This month, the industry saw progression in rare…
PharmaVOICE Webinar: Next Gen Commercialization Model for Oncology
In a new 60-minute virtual panel, “Next Gen Commercial Models in Oncology,” PharmaVOICE Editor Taren Grom sat down with industry leaders to discuss how changing market dynamics and a rich pipeline in oncology are creating a…
Ask the Expert: One-on-One with Amy Hutnik
The pharma industry’s needs have evolved beyond one-dimensional playbooks, disconnected promotional efforts and limited ability to assess stakeholder engagement. Instead, manufacturers need to adopt a comprehensive omnichannel model that allows for data-driven planning and real-time analysis…
Ask the Expert: One-on-One with Krista Pinto
Forty percent of worldwide drug launches between 2009 and 2017 failed to meet their two-year sales forecasts. Manufacturers can’t afford to overlook the full potential of a data-driven omnichannel strategy. Omnichannel success requires a comprehensive suite…
BLOG: Gaining Coverage for Emerging Medical Technologies
Posted by
Dr. Richard Stefanacci on 6 月 15, 20216/15/21
The line between medical and personal care is everchanging. In all areas of our lives there is coverage through medical benefits, but the exact line between this and one’s personal responsibilities is not always as clear,…
Omnichannel: A Conversation With the Innovators
Go beyond marketing to provide actionable insights that better inform commercial strategies and elevate brand success. EVERSANA’s best-in-class omnichannel activation model aggregates and synthesizes pivotal datasets from marketing campaigns, patient services programs and field activities to analyze…
Webinar: Medicaid & Government Pricing Congress
In this Medicaid & Government Pricing Congress panel, EVERSANA’s Mike Kurland, Vice President, Revenue Management and Compliance Solutions, discusses upcoming regulatory changes impacting government pricing and how to manage challenging reporting issues with calculation. How to…
Pharma USA Webinar: Hot For Hybrid: Building Medical Field Teams For Healthcare’s New Normal
Posted on 6 月 11, 20216/11/21
Hot For Hybrid: Building Medical Field Teams For Healthcare’s New Normal Featuring EVERSANA’s Marc Bernarducci, Senior Vice President of Field Solutions — Clinical This panel covers the following topics: Review the implications of new field force…
Pharma USA Webinars: Personalize HCP Experiences for Deeper Engagement
EVERSANA was proud to participate in two Pharma USA 2021 sessions. This webinar, featuring EVERSANA’s Amy Hutnik, General Manager, Agency, Advisory and Evidence Services, covers the following topics: Harnessing AI to inform your sales approach and…
Beyond the New Normal: Reshaping Life Sciences Pricing Strategies in a Complex Global Scenario
This Life Sciences Dynamic Talks session takes a close look at the future of life sciences pricing strategies in the “new normal.” From non-traditional blocs to Brexit and the rise of net price transparency, a number…